| |
 |
SYM |
Description |
 |
|
ENDO |
Diagnostic technology for the identification of prostate abnormalities, including prostate cancer |
 |
|
|
|
|
|
|
|
Private |
Minimally invasive intravascular systems for implementing targeted renal therapy. |
|
|
|
|
|
|
|
|
GENZ |
A product portfolio focused on rare genetic disorders, renal disease and osteoarthritis. |
|
|
|
|
|
|
|
|
SORN |
Products used to treat cardiovascular and renal diseases. |
|
|
|
|
|
|
|
|
Private |
Critical blood and cell-related products and renal care. |
|
|
|
|
|
|
|
|
private |
Device and services for patients with chronic and acute kidney failure. |
|
|
|
|
|
|
|
|
|
Aksys has ceased operations.
|
|
|
|
|
|
|
|
|
Private |
Developing novel drugs to treat renal and vascular diseases |
|
|
|
|
|
|
|
|
Private |
Minimally invasive surgical techniques which form precisely controlled connections throughout the body. |
|
|
|
|
|
|
|
|
Private |
National network of dialysis clinics for the treatment of End- Stage Renal Disease. |
|
|
|
|
|
|
|
|
Private |
Non-absorbed, GI based drugs for renal and metabolic diseases |
|
|
|
|
|
|
|
|
|
Acquired by Fresenius Medical Care March 2006 |
|
|
|
|
|
|
|
|
FMS |
Products and services for individuals with chronic kidney failure. |
|
|
|
|
|
|
|
|
Private |
Pharmaceuticals for the treatment of inflammatory and immune mediated diseases. |
|
|
|
|
|
|
|
|
Private |
Hemodialysis and peritoneal dialysis services for end stage renal disease. |
|
|
|
|
|
|
|
|
Private |
Pharmaceutical products for renal, gastrointestinal and metabolic diseases. |
|
|
|
|
|
|
|
|
Private |
Pharmaceutical company with its own development and manufacturing. |
|
|
|
|
|
|
|
|
Private |
Contract research for major disease clinical development programs. |
|
|
|
|
|
|
|
Pharminox |
|
Steventon, Abingdon, |
United Kingdom |
|
Private |
Small molecule oncology research and development. |
|
|
|
|
|
|
|
|
Private |
In vivo, preclinical, laboratory services for the pharmaceutical and biotech industy. |
|
|
|
|
|
|
|
|
Private |
Drug efficacy and safety evaluation in animal pharmacology. |
|
|
|
|
|
|
|
|
Private |
Phase I-IV clinical trial site and site management. |
|
|
|
|
|
|
|
|
Private |
Contract manufacturing for oral liquid pharmaceutical formulation and dosage forms. |
|
|
|
|
|
|
|
|
Private |
Multisource proteins for anemia, cancer, and renal disease. |
|
|
|
|
|
|
|
|
Private |
Drugs primarily for cardiovascular diseases. |
|
|
|
|
|
|
|
|
DVA |
Provider of dialysis services for patients with ESRD. |
|
|
|
|
|
|
|
|
NXTM |
Systems for the treatment of end-stage renal disease, acute kidney failure and fluid overload.
|
|
|
|
|
|
|
|
Kimal |
|
Uxbridge, Middlesex, UK |
United Kingdon |
|
Private |
Specialist medical distribution company. |
|
|
|
|
|
|
|
|
GENZ |
Genzyme is a biotech company dedicated to making an impact on the lives of people with serious diseases. |
|
|
|
|
|
|
|
|
NEP |
Technologies for end stage renal disease and water filtration |
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
OneMedPlace Member
